MedPath

LUCENT Tablet

Registration Number: MAL18016121NCR

Approved
Approval ID

0963acddd0fd9cd2

Registration Number

MAL18016121NCR

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (2)

30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (4)

ASCORBYL PALMITATEActive
Monograph: ascorbyl palmitate
LYCOPERSICON ESCULENTUM (TOMATO)Active
Monograph: lycopersicon esculentum (tomato)
L-CYSTEINEActive
Monograph: 半胱氨酸
COENZYME Q10 (UBIQUINONE)Active
Monograph: coenzyme q 10 (ubiquinone)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LUCENT Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform